2023-10-03 21:43:24
The US Food and Drug Administration said on Tuesday that it had authorized an updated version of the Covid-19 vaccine produced by Novavax for emergency use in individuals who are at least 12 years old.
Last month, the director of the US Centers for Disease Control and Prevention approved the widespread use of updated competing Covid-19 vaccines from Pfizer in partnership with the German BioNTech, as well as from Moderna.
A spokesman for the CDC’s Advisory Committee on Immunization Practices said that the committee will not meet again to discuss approval of the Novavax vaccine.
The spokesman added, “The committee’s recommendation last month, which was then approved by the director of the centers, was to include all updated Covid-19 vaccines licensed or approved by the FDA, including those expected to be licensed or authorized for use in the coming months.” “.
The three updated vaccines target the XPB1.5 submutant of the Omicron variant of the coronavirus. XPB1.5 remained prevalent in the United States for most of this year, but new variants have since taken over.
1696388615
#Food #Drug #Administration #approves #updated #Covid #vaccine #Novavax